Showing 241-250 of 7932 results for "".
Reap What You Sow: Thoughtfully Interviewing for Medical Aesthetic Providers
https://practicaldermatology.com/topics/practice-management/reap-what-you-sow-thoughtfully-interviewing-for-medical-aesthetic-providers/23208/How to implement a strategic interviewing process that will help you find providers who fit your practice and culture.Improve Search Marketing with Consistent, Accurate Local Listings
https://practicaldermatology.com/topics/practice-management/improve-search-marketing-with-consistent-accurate-local-listings/23095/Get the inside scoop on local search marketing.Use Instagram to Promote Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/use-instagram-to-promote-your-dermatology-practice/20351/Instagram can help a practice promote products and services without incurring significant expenses for advertising.New Therapeutic Options for the Treatment of Psoriatic Arthritis: IL-17 Blockers
https://practicaldermatology.com/topics/psoriasis/new-therapeutic-options-for-the-treatment-of-psoriatic-arthritis-il-17-blockers/20447/Are TNF inhibitors still the gold standard for PsA?Bio-Logistics: Steps for Improving Access to Biologic Therapy
https://practicaldermatology.com/topics/practice-management/bio-logistics-steps-for-improving-access-to-biologic-therapy/21192/Dealing with insurance companies can be a burden for many practices, but here are some steps to help expedite the process.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know?
https://practicaldermatology.com/topics/infections-infectious-disease/systemic-corticosteroids-chronic-inflammatory-skin-disease-and-covid-19-what-do-we-know/23615/An assessment of the risk of COVID-19 infection imposed by systemic corticosteroid use in the setting of chronic inflammatory skin disease.Everything Old Is New Again: Re-assessing IPL
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/everything-old-is-new-again-re-assessing-ipl/23013/Long-term IPL use may turn the tables on aging skin.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/series/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Impetigo: An Unconventional Case Report
https://practicaldermatology.com/topics/rare-disease/impetigo-an-unconventional-case-report/26246/Mauri Hart, a medical student at the Oklahoma State University College of Osteopathic Medicine, takes a look at a unique case study, and tests the reader's knowledge of impetigo.